Experimental drug inhibits or prevents diabetic eye disease

Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. CU Department of Ophthalmology faculty Miguel Flores-Bellver, PhD, and Maria Valeria Canto-Soler, PhD, contributed to the study with other researchers, finding a compound called 32-134D, previously shown to slow liver tumor growth in mice, prevented diabetic retinal vascular disease by decreasing levels of a protein called HIF, or hypoxia-inducible factor.